Cas no 1197-01-9 (2-(4-Methylphenyl)propan-2-ol)
2-(4-Methylphenyl)propan-2-ol Chemical and Physical Properties
Names and Identifiers
-
- 2-(4-Methylphenyl)propan-2-ol
- alpha,alpha,4-Trimethylbenzyl alcohol
- 8-HYDROXY PARA-CYMENE
- 2-p-Tolyl-2-propanol
- 4-methylcumyl alcohol
- 8-Hydroxy-p-cymene
- Cymen-8-ol,p
- Dimethyl-p-tolyl carbinol
- FEMA No. 3242
- p-Cymen-8-ol
- p-methylcumyl alcohol
- p-tolyl-dimethylcarbinol
- 2-(4-Methylphenyl)-2-propanol
- Cymen-8-ol, p-
- 1-Methyl-4-(1-hydroxy-1-methylethyl)benzene
- 2-p-tolylpropan-2-ol
- 2-(P-Methylphenyl)-2-propanol
- P-CYMENE-8-OL
- 2-(p-tolyl)propan-2-ol
- para-Cymen-8-ol
- p,alpha,alpha-Trimethylbenzyl alcohol
- p-Cymenol-8
- alpha,alpha,4-Trimethylbenzenemethanol
- Benzenemethanol, alpha,alpha,4-
-
- MDL: MFCD00029997
- Inchi: 1S/C10H14O/c1-8-4-6-9(7-5-8)10(2,3)11/h4-7,11H,1-3H3
- InChI Key: XLPDVYGDNRIQFV-UHFFFAOYSA-N
- SMILES: CC1C=CC(C(O)(C)C)=CC=1
Computed Properties
- Exact Mass: 150.10400
- Monoisotopic Mass: 150.104465
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 121
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: 2
- Topological Polar Surface Area: 20.2
Experimental Properties
- Color/Form: Colorless to yellowish liquid with a celery like odor
- Density: 0.97?g/mL?at 25?°C(lit.)
- Boiling Point: 64?°C0.6?mm Hg(lit.)
- Flash Point: 205?°F
- Refractive Index: n20/D 1.5185(lit.)
- Stability/Shelf Life: Stable. Combustible. Incompatible with strong oxidizing agents.
- PSA: 20.23000
- LogP: 2.22240
- FEMA: 3242 | P-ALPHA,ALPHA-TRIMETHYLBENZYL ALCOHOL
- Solubility: Slightly soluble in water
2-(4-Methylphenyl)propan-2-ol Customs Data
- HS CODE:2902909090
- Customs Data:
China Customs Code:
2902909090Overview:
2902909090. Other aromatic hydrocarbons. VAT:17.0%. Tax refund rate:9.0%. Regulatory conditions:nothing. MFN tariff:2.0%. general tariff:30.0%
Declaration elements:
Product Name, component content
Summary:
2902909090 other aromatic hydrocarbons.Supervision conditions:None.VAT:17.0%.Tax rebate rate:9.0%.MFN tariff:2.0%.General tariff:30.0%
2-(4-Methylphenyl)propan-2-ol Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | W324205-SAMPLE-K |
2-(4-Methylphenyl)propan-2-ol |
1197-01-9 | ≥95%, FG | 587.6 | 2021-05-17 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | W324205-100G-K |
2-(4-Methylphenyl)propan-2-ol |
1197-01-9 | ≥95%, FG | 100G |
1382.97 | 2021-05-17 | |
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | W324205-1KG-K |
2-(4-Methylphenyl)propan-2-ol |
1197-01-9 | ≥95%, FG | 1KG |
9867.82 | 2021-05-17 | |
| TRC | M327715-10g |
2-?(4-?Methylphenyl)?propan-?2-?ol |
1197-01-9 | 10g |
55.00 | 2021-07-28 | ||
| TRC | M327715-50g |
2-?(4-?Methylphenyl)?propan-?2-?ol |
1197-01-9 | 50g |
215.00 | 2021-07-28 | ||
| TRC | M327715-100g |
2-?(4-?Methylphenyl)?propan-?2-?ol |
1197-01-9 | 100g |
350.00 | 2021-07-28 | ||
| TRC | M327715-250g |
2-?(4-?Methylphenyl)?propan-?2-?ol |
1197-01-9 | 250g |
730.00 | 2021-07-28 | ||
| abcr | AB430365-1 g |
2-(4-Methylphenyl)-2-propanol; . |
1197-01-9 | 1g |
€594.40 | 2023-04-23 | ||
| abcr | AB430365-5 g |
2-(4-Methylphenyl)-2-propanol; . |
1197-01-9 | 5g |
€1,398.00 | 2023-04-23 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | M47120-100g |
2-(4-Methylphenyl)propan-2-ol |
1197-01-9 | 100g |
¥1328.0 | 2021-09-08 |
2-(4-Methylphenyl)propan-2-ol Suppliers
2-(4-Methylphenyl)propan-2-ol Related Literature
-
Martta Asikainen,Olli Jauhiainen,Olli Aaltonen,Ali Harlin Green Chem. 2013 15 3230
-
Igor Jerkovi?,Piotr Marek Ku? RSC Adv. 2014 4 31710
-
Yasushi Nishihara,Yasuhiro Nishide,Kohtaro Osakada Dalton Trans. 2021 50 3610
-
Claudia Russo-Caia,Steen Steenken Phys. Chem. Chem. Phys. 2002 4 1478
-
Huaixiang Tian,Zhuoyan Lu,Haiyan Yu,Chen Chen,Jing Hu Food Funct. 2019 10 2595
Related Categories
- Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropanes
- Natural Products and Extracts Plant Extracts Plant based Echinophora tournefortii
- Natural Products and Extracts Plant Extracts Plant based Echinophora orientalis
- Natural Products and Extracts Plant Extracts Plant based Anisosciadium orientale
Additional information on 2-(4-Methylphenyl)propan-2-ol
Recent Advances in the Study of 2-(4-Methylphenyl)propan-2-ol (CAS: 1197-01-9) in Chemical Biology and Pharmaceutical Research
The compound 2-(4-Methylphenyl)propan-2-ol (CAS: 1197-01-9) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug development and organic synthesis. This research briefing aims to provide a comprehensive overview of the latest findings related to this compound, focusing on its synthesis, biological activities, and potential therapeutic applications. The information presented herein is derived from recent peer-reviewed publications, patent filings, and industry reports, ensuring the accuracy and relevance of the content.
Recent studies have highlighted the role of 2-(4-Methylphenyl)propan-2-ol as a key intermediate in the synthesis of various bioactive molecules. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated its utility in the development of novel anti-inflammatory agents. The researchers employed a multi-step synthetic route to derivatize the compound, resulting in analogs with enhanced potency and selectivity against cyclooxygenase-2 (COX-2). These findings underscore the potential of 2-(4-Methylphenyl)propan-2-ol as a scaffold for designing next-generation anti-inflammatory drugs.
In addition to its synthetic applications, 2-(4-Methylphenyl)propan-2-ol has been investigated for its intrinsic biological properties. A recent preprint on bioRxiv reported its moderate inhibitory activity against certain bacterial strains, including Staphylococcus aureus and Escherichia coli. Although the exact mechanism of action remains under investigation, preliminary data suggest that the compound disrupts bacterial cell membrane integrity. This discovery opens new avenues for exploring its use as an antimicrobial agent, particularly in the context of rising antibiotic resistance.
From a pharmacological perspective, the metabolic fate of 2-(4-Methylphenyl)propan-2-ol has been a subject of interest. A 2024 study in Drug Metabolism and Disposition utilized advanced LC-MS techniques to characterize its phase I and phase II metabolites in human liver microsomes. The results indicated that the compound undergoes rapid hydroxylation followed by glucuronidation, with a half-life of approximately 2.5 hours. These pharmacokinetic insights are crucial for optimizing its therapeutic potential and minimizing potential toxicity.
Industry reports also highlight the growing commercial interest in 2-(4-Methylphenyl)propan-2-ol. Several pharmaceutical companies have included derivatives of this compound in their preclinical pipelines, targeting indications such as chronic pain and neurodegenerative disorders. Patent filings from 2023-2024 reveal novel formulations that enhance the compound's bioavailability, including nanocrystalline and lipid-based delivery systems. These developments suggest that 2-(4-Methylphenyl)propan-2-ol may transition from a research chemical to a clinically relevant entity in the near future.
In conclusion, the body of research surrounding 2-(4-Methylphenyl)propan-2-ol (CAS: 1197-01-9) continues to expand, revealing its multifaceted roles in drug discovery and development. While challenges such as metabolic stability and target selectivity remain, recent advancements in synthetic chemistry and formulation technology offer promising solutions. Future studies should focus on elucidating its structure-activity relationships and exploring its potential in combination therapies. This compound exemplifies how fundamental chemical research can translate into tangible therapeutic innovations.
1197-01-9 (2-(4-Methylphenyl)propan-2-ol) Related Products
- 599-67-7(1,1-Diphenylethanol)
- 76-84-6(Triphenyl methanol)
- 3247-00-5(4,4',4''-Trimethyltrityl alcohol)
- 617-94-7(2-Phenyl-2-propanol)
- 2948-46-1(alpha,alpha,alpha',alpha'-Tetramethyl-1,4-benzenedimethanol)
- 1999-85-5(alpha,alpha'-Dihydroxy-1,3-diisopropylbenzene)
- 19576-38-6(1,3,5-Benzenetrimethanol,a1,a1,a3,a3,a5,a5-hexamethyl-)
- 14860-89-0(2-3-(propan-2-yl)phenylpropan-2-ol)
- 131612-90-3(Partricin, methylester, mixt. with O-2-naphthalenyl methyl(3-methylphenyl)carbamothioate (9CI))
- 12687-94-4(Praseodymium hydroxide)